论文部分内容阅读
实验动物和人类的很多肿瘤分泌免疫反应性胰岛素(简称IRI),常引起宿主低血糖。相反,恶性肿瘤的生长依赖于胰岛素和在大多数情况下它消耗胰岛素。故检测恶性肿瘤患者血中IRI水平可能是一项有用而重要的参数,血中糖和IRI水平可能与疾病的分期和患者状况相关。作者检测了50例各期何杰金氏病患者血中IRI和糖的水平,某些还检查了脾切除术后患者血中IRI和脾浸出物中IRI的含量。发现当病人于缓解时其IRI含量降低而复发时升高,从而血糖值在
Many tumors in experimental animals and humans secrete immunoreactive insulin (IRI for short), often causing hypoglycemia in the host. In contrast, the growth of malignancies is dependent on insulin and in most cases it consumes insulin. Therefore, the detection of IRI levels in the blood of patients with malignant tumors may be a useful and important parameter, blood sugar and IRI levels may be related to the stage of the disease and the patient’s condition. The authors examined the levels of IRI and sugars in blood from 50 patients with Hodgkin’s disease and some also examined the levels of IRI in the blood and spleen extracts of patients after splenectomy. Found that when the patient in the alleviation of IRI content decreased and relapse increased, so the blood glucose in the